“Weight loss can improve glucose metabolism, necessitating a lower dosage of insulin or other diabetes medications to prevent the risk of hypoglycemia and optimize treatment effectiveness,” says @Zilbermint, chief of Endocrinology, Diabetes and Metabolism at Suburban Hospital JHM. ⬇️⬇️⬇️

Mihail "Misha" Zilbermint, MD, MBA Suburban Hospital JHM Read more in this article from Verywell Health, "Could Wegovy Help You Cut Down on Other Medications?" bit.ly/3Q1rogU

.⁦Dr. Susan Samson⁩ kicks off the #AACE2024 ⁦AACE⁩

If there a risk of periop compli w #GLP1a AACE Endocrine Society ADA Professional Publications American Diabetes Association - DiabetesPro Daniel J Drucker Beverly G. Tchang, MD Miller Medicine Cristobal Morales mariagrazia girone Prof Kamlesh Khunti Georgia Center for Diabetes Translation Research Javier Escalada #Yoelijoendocrino Ted Kyle Mohammed K Ali Rozalina (Grubina) McCoy, MD MS …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…

You (almost) never know if the patient is going to eat- it’s reasonable to administer insulin after the meals.

Great piece by Miriam E. Tucker from Medscape about the timing of #insulin administration in the #hospital and hypoglycemia reduction. medscape.com/viewarticle/sh…

New commentary on the ADA guidelines on DKA #EndocrinePractice by Drs Swapnil Khare, Garg, Shah and Mihail "Misha" Zilbermint, MD, MBA Navigating the New Frontiers of Hyperglycemic Crisis Management: Unveiling the Latest American Diabetes Association Consensus Report endocrinepractice.org/article/S1530-…

🚀 Exciting News! Our #EndocrineHospitalist team just published "Inpatient #Diabetes Management" in NYAS! Johns Hopkins Medicine Johns Hopkins Howard County Medical Center Sibley Hospital JHM Suburban Hospital JHM Division of Endocrinology doi.org/10.1111/nyas.1…

Q&A: New guidance for monitoring pre-symptomatic type 1 diabetes healio.com/news/endocrino… Breakthrough T1D AACE Diabetes Care, a research journal of the ADA 🌟 ADA Professional Publications Northwell Department of Medicine Yael Tobi Harris

Excited to share the publication of our new book chapter new insights/ insulin and non-insulin approaches based on most recent guidelines. Inpatient management of type 2 diabetes. Special thanks to Mihail "Misha" Zilbermint, MD, MBA for this opportunity. Houston Methodist MD Houston Methodist Aisha

#CMS will hold hospitals accountable for not reporting poor #glycemic outcomes. Will this make our hospitals safer for people living with #diabetes? doi.org/10.1177/193229…

Just published a new case report in AACE #ClinicalCaseReports! It highlights the successful use of hyperinsulinemic-euglycemic therapy for severe calcium channel blocker overdose. aaceclinicalcasereports.com/article/S2376-…

A summary of the updated American Diabetes Association consensus report on hyperglycemic crisis management, which has been endorsed jointly by AACE, EASD, Joint British Diabetes Societies – Inpatient Care, Diabetes Technology. Read more: endocrinepractice.org/article/S1530-… @Els_ENDO Vin Tangpricha, MD, PhD #endocrinology

A summary of the updated American Diabetes Association consensus report on hyperglycemic crisis management, which has been endorsed jointly by AACE, EASD, Joint British Diabetes Societies – Inpatient Care, Diabetes Technology. Read more: endocrinepractice.org/article/S1530-… @Els_ENDO Vin Tangpricha, MD, PhD #endocrinology

What a wonderful collaboration! Thanks to AACE for the invitation to join the effort!

📱 MARD values between CGM and other #glucose measurement methods are not associated with laboratory values or vital signs, which provides “reassurance regarding the use of CGMs in the hospital setting." Mayo Clinic Mihail "Misha" Zilbermint, MD, MBA healio.com/news/endocrino…

📣 "CGMs brought from home demonstrated strong accuracy across a diverse hospitalized population, with more than 98% of values in clinically acceptable error grid zones." Mayo Clinic Mihail "Misha" Zilbermint, MD, MBA #diabetes #glucose healio.com/news/endocrino…

“We need to treat prediabetes as an actual diagnosis — not just a warning sign.” says Johns Hopkins Medicine endocrinologist Mihail "Misha" Zilbermint, MD, MBA. From Screening to Intervention: Optimizing Prediabetes Care in Primary Care Settings. Medscape wb.md/3Sqpk2Q

.Johns Hopkins Medicine endocrinologist Mihail "Misha" Zilbermint, MD, MBA discusses how Eli Lilly's obesity pill could be a game changer for patients. CNBC cnbc.com/2025/08/07/eli…

Check out Endocrine Society's 2023 Clinical Practitioner Laureate Award recipient Mihail "Misha" Zilbermint, MD, MBA discussing Eli Lilly and Company's new #obesity pill: cnbc.com/2025/08/07/eli…